News and Breakthroughs
Research scientists at Cedars-Sinai continually advance a new understanding of diseases, as well as new ideas and technologies for prevention and treatment. This diligence generates a steady stream of news about their transformational achievements and their benefits to healthcare.
Allowing pharmacists in the emergency department to order redosing of antibiotics for patients experiencing extended wait times for an in-hospital bed, rather requesting those doses through a physician, may reduce dosing delays and prevent infection-related deaths, according to a Cedars-Sinai study published in the American Journal of Emergency Medicine.
Patients with inflammatory bowel disease (IBD) who received the COVID-19 vaccine from Johnson & Johnson produced significantly lower levels of antibodies against the SARS-CoV-2 virus than those who received the Pfizer-BioNTech or Moderna vaccines, according to a study led by Cedars-Sinai.
Cedars-Sinai investigators have made significant progress in identifying the mechanisms behind idiopathic pulmonary fibrosis, a deadly disease that scars the lungs and impairs breathing.